Cargando…

Biochemical recurrence related metabolic novel signature associates with immunity and ADT treatment responses in prostate cancer

BACKGROUND: Prostate cancer (PCa) is a unique cancer from a metabolic perspective. Androgen receptor assumes a vital part in normal and malignant prostate cells regarding almost all aspects of cell metabolism, such as glucose, fat, amino acids, nucleotides, and so on. METHODS: We used The Cancer Gen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Xuan, Lv, Zhengtong, Xia, Haoran, Guo, Xiaoxiao, Wang, Jianye, Wang, Jianlong, Liu, Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9844602/ https://www.ncbi.nlm.nih.gov/pubmed/35681277 http://dx.doi.org/10.1002/cam4.4856

Ejemplares similares

Identifying a Ferroptosis-Related Gene Signature for Predicting Biochemical Recurrence of Prostate Cancer
por: Lv, Zhengtong, et al.
Publicado: (2021)

Identification of a Hypoxia-Related Gene Signature for Predicting Systemic Metastasis in Prostate Cancer
por: Xia, Haoran, et al.
Publicado: (2021)

Immune signature driven by ADT-induced immune microenvironment remodeling in prostate cancer is correlated with recurrence-free survival and immune infiltration
por: Long, Xingbo, et al.
Publicado: (2020)

A Novel Gene Signature Associated With “E2F Target” Pathway for Predicting the Prognosis of Prostate Cancer
por: Xia, Haoran, et al.
Publicado: (2022)

Transport of ADT
por: Juha Sakkinen
Publicado: (2006)

Comprehensive Analysis of N6-methyladenosine Modification Patterns Associated With Multiomic Characteristics of Bladder Cancer
por: Liu, Jingchao, et al.
Publicado: (2021)

Enzalutamide + androgen deprivation therapy (ADT) versus flutamide + ADT in Japanese men with castration‐resistant prostate cancer: AFTERCAB study
por: Uemura, Hiroji, et al.
Publicado: (2021)

ADT and OBSBOX in 2016
por: Valuch, D, et al.
Publicado: (2017)

Identification of a novel senescence-associated signature to predict biochemical recurrence and immune microenvironment for prostate cancer
por: Han, Chenglin, et al.
Publicado: (2023)

Predictive role of ferroptosis-related long non-coding RNAs in bladder cancer and their association with immune microenvironment and immunotherapy response
por: Liu, Jingchao, et al.
Publicado: (2022)

The impact of hegemonic masculine ideals on self‐esteem in prostate cancer patients undergoing androgen deprivation therapy (ADT) compared to ADT‐naïve patients
por: Gentili, Caterina, et al.
Publicado: (2022)

ADT fast losses MD
por: Priebe, A, et al.
Publicado: (2013)

An Immune-Related lncRNA Signature to Predict the Biochemical Recurrence and Immune Landscape in Prostate Cancer
por: Zhang, Guian, et al.
Publicado: (2021)

Utilizing metformin to prevent metabolic syndrome due to androgen deprivation therapy (ADT): a randomized phase II study of metformin in non-diabetic men initiating ADT for advanced prostate cancer
por: Mahalingam, Devalingam, et al.
Publicado: (2023)

The ferroptosis-related long non-coding RNAs signature predicts biochemical recurrence and immune cell infiltration in prostate cancer
por: Liu, Chunhui, et al.
Publicado: (2022)

Correction: Utilizing metformin to prevent metabolic syndrome due to androgen deprivation therapy (ADT): a randomized phase II study of metformin in non-diabetic men initiating ADT for advanced prostate cancer
por: Mahalingam, Devalingam, et al.
Publicado: (2023)

Construction and External Validation of a Ferroptosis-Related Gene Signature of Predictive Value for the Overall Survival in Bladder Cancer
por: Liu, Jingchao, et al.
Publicado: (2021)

The effect of strength training on muscle cellular stress in prostate cancer patients on ADT
por: Nilsen, T S, et al.
Publicado: (2016)

ADT and RF after LS1
por: Butterworth, A, et al.
Publicado: (2015)

Weniger Corona-Infektionen unter ADT?
por: Bublak, Robert
Publicado: (2020)

Bridging Arrays and ADTs in Recursive Proofs
por: Fedyukovich, Grigory, et al.
Publicado: (2021)

Comparing the Survival Outcomes of Radical Prostatectomy Versus Radiotherapy for Patients With De Novo Metastasis Prostate Cancer: A Population-Based Study
por: Guo, Xiaoxiao, et al.
Publicado: (2021)

Efficacy and Safety of Combined Androgen Deprivation Therapy (ADT) and Docetaxel Compared with ADT Alone for Metastatic Hormone-Naive Prostate Cancer: A Systematic Review and Meta-Analysis
por: Botrel, Tobias Engel Ayer, et al.
Publicado: (2016)

A Novel Four Mitochondrial Respiration-Related Signature for Predicting Biochemical Recurrence of Prostate Cancer
por: Xia, Zhongyou, et al.
Publicado: (2023)

Targeting ADT-Induced Activation of the E3 Ubiquitin Ligase Siah2 to Delay the Occurrence of Castration-Resistant Prostate Cancer
por: Yan, Tingmang, et al.
Publicado: (2021)

Adjusting the duration of androgen deprivation therapy (ADT) based on nadir PSA for high risk localized prostate cancer patients treated with definitive external beam radiation therapy and ADT
por: Ayoub, Zeina, et al.
Publicado: (2022)

Acidovorax citrulli Effector AopV Suppresses Plant Immunity and Interacts with Aromatic Dehydratase ADT6 in Watermelon
por: Jiang, Jie, et al.
Publicado: (2022)

Timing of exercise for muscle strength and physical function in men initiating ADT for prostate cancer
por: Newton, Robert U., et al.
Publicado: (2020)

Severity of COVID-19 infection in prostate cancer patients and effect of ADT on disease presentation
por: García Fuentes, C., et al.
Publicado: (2021)

Identification and validation of a lipid metabolism gene signature for predicting biochemical recurrence of prostate cancer after radical prostatectomy
por: Cai, Yingxin, et al.
Publicado: (2022)

Palliative TURP Combined with Intermittent ADT Is A Curative Therapy to Some Elderly Men with Localized Prostate Adenocarcinoma
por: Zhang, Xu, et al.
Publicado: (2023)

Identification and validation of a six immune-related gene signature for prediction of biochemical recurrence in localized prostate cancer following radical prostatectomy
por: Luan, Jiaochen, et al.
Publicado: (2021)

A cuproptosis-related LncRNA signature: Integrated analysis associated with biochemical recurrence and immune landscape in prostate cancer
por: Ren, Lei, et al.
Publicado: (2023)

The LHC Transverse Damper (ADT) Performance Specification
por: Boussard, Daniel, et al.
Publicado: (2000)

Ferroptosis Mediation Patterns Reveal Novel Tool to Implicate Immunotherapy and Multi-Omics Characteristics in Bladder Cancer
por: Liu, Jingchao, et al.
Publicado: (2022)

Identification of Pyroptosis-Related Gene Signatures and Construction of the Risk Model to Predict BCR in Prostate Cancer
por: Wang, Miaomiao, et al.
Publicado: (2022)

The Use of Androgen Deprivation Therapy (ADT) and Chemotherapeutic Agents in New Zealand Men with Prostate Cancer
por: Lawrenson, Ross, et al.
Publicado: (2014)

International survey of androgen deprivation therapy (ADT) for non-metastatic prostate cancer in 19 countries
por: Liede, Alexander, et al.
Publicado: (2016)

FOXM1-regulated ZIC2 promotes the malignant phenotype of renal clear cell carcinoma by activating UBE2C/mTOR signaling pathway
por: Lv, Zhengtong, et al.
Publicado: (2023)

Noise studies with new ADT pickups (MD4143)
por: Buffat, Xavier, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5qt6ca7knrob2je22kvbprm0v7